 |
 |
CAPABILITIES
• Risk management and public policy
• Toxicology and risk assessment
• Pro bono activities
Risk Management and
Public Policy
HealthRisk Strategies provides support on
issues related to how science and risk information is used in US and
international decisions about the best ways to manage, reduce, or
eliminate risks to health from environmental or occupational
exposures.
Organizations retain me to:
-
Comment on proposed risk policies
-
Advocate for sound science in public
policy
-
Testify to advisory bodies on science
policy and regulatory implementation issues
-
Write reports on regulatory and science
policy issues for publication
-
Help preserve a role for science in
collaborative decision-making processes
For example, I have:
-
Provided testimony to EPA’s Science
Advisory Board on the children’s health aspects of EPA’s proposed cancer
risk assessment guidelines.
-
Provided testimony to EPA’s Science
Advisory Board on the complementary roles of science and public
involvement in science policy decision-making.
-
Advised EPA’s Children’s Health Protection
Advisory Committee on the use of human data for research and regulation.
-
Published several papers in peer-reviewed
journals on children’s environmental health and regulation.
-
Conducted a meta analysis of studies on
the effects of age on chemically induced carcinogenesis in rodents and
evaluating its implications for regulatory strategies directed towards
protecting children’s health.
-
Provided testimony to the National Academy
of Sciences Committee on the Use of Third Party Toxicity Research with
Human Research Participants.
-
Published two papers on the science,
ethics, and law surrounding the use of human subjects testing data in
chemical regulation.
-
Developed recommendations on risk-based
decision-making and the role of the precautionary principle for the
European Commission.
-
Organized and participated in symposia
aimed at strengthening risk-based regulatory agendas in Europe and South
America.
-
Provided comments to EPA on its proposed
Clean Air Act implementation policies.
-
Provided testimony to EPA’s Office of
Research and Development on its proposed revised cancer risk assessment
guidelines.
-
Provided testimony to the National
Toxicology Program on its carcinogen listing process.
-
Developed recommendations advocating a
role of credible science in stakeholder-based risk management
decision-making processes.
Toxicology and
Risk Assessment
HealthRisk Strategies helps develop and
reviews chemical-specific risk assessments and risk assessment
methodology, makes recommendations about the likelihood that
particular exposures may be associated with adverse health impacts,
and provides toxicologic support for risk-related litigation.
Organizations retain me to:
-
Peer-review risk assessments
-
Peer-review risk methods
-
Evaluate worker or environmental exposures
and their likely health impacts
-
Provide scientific and technical support
for cases of liability and toxic tort
-
Author papers on chemical risks
For example, I have:
-
Reviewed and commented on EPA’s proposed
methods for assessing the contribution of childhood carcinogen exposures
to lifetime excess cancer risk.
-
Provided comments to EPA during the
development of a cumulative risk assessment of organophosphate pesticides.
-
Co-authored a paper on risks from
organophosphate pesticides as estimated from biomarkers or from different
risk models.
-
Peer-reviewed EPA’s proposed Framework for
Cumulative Risk Assessment.
-
Chaired the peer review of EPA’s proposed
risk assessment methodology for complex mixtures.
-
Advised a client on the likelihood that
their new product would pose a health risk to workers.
-
Participated on an expert committee
evaluating the public health impact of styrene.
-
Provided expert witness support to several
law firms.
-
Assessed the primary risks to human health
from environmental and occupational exposures to hazardous substances in
Romania, including evaluating the institutional and regulatory issues
related to characterizing and remediating hazardous exposures and
developed a national environmental health strategy.
-
Assessed risks to health and the
environment associated with emissions from an antiquated copper smelter in
Transylvania.
Pro bono
activities
-
Member, National Academy of Sciences Board
on Environmental Studies & Toxicology
-
Member, California Green Chemistry
Initiative's Science Advisory Panel, 2008
-
Member, National Academy of Sciences Low
Activity Waste Committee (recommending risk-informed policies for low-level
radioactive waste disposal), 2004-2007
-
Member, National Academy of Sciences
Committee on Toxicity Testing of Environmental Agents (recommending
toxicity testing vision for the 21st century), 2004-2007
-
Member, National Toxicology Program’s
Report on Carcinogens Committee, 2002-2005
-
Involved in the leadership of the
international Society for Risk Analysis, 1994-present
-
Program committee co-chair, First and
Second World Congresses
on Risk
-
Board member, Environmental Law Institute,
2003-2009
-
Board member, Toxicology Excellence for
Risk Assessment
-
Adjunct faculty, Harvard School of Public
Health, 2002-2005
-
Adjunct faculty, George Mason University
Law School, 2004
|
|